Sapar, Apao .

HRN: 26-61-63  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/08/2025
02/14/2025
IV
4.5g
Q8H
CAP MR
Rejected 

 Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines